Pseudohypoparathyroidism: complex disease variants with unfortunate names

Area of Science:

• Genetics
• Endocrinology
• Molecular Biology

Background:

• The GNAS locus on chromosome 20q13.3 encodes the stimulatory G protein alpha-subunit (Gsα) and its variants.
• Disorders such as pseudohypoparathyroidism (PHP) arise from genetic or epigenetic GNAS alterations.
• These alterations impact Gsα function, leading to hormonal resistance and associated phenotypes like Albright's hereditary osteodystrophy (AHO).

Purpose of the Study:

• To elucidate the genetic and epigenetic mechanisms underlying GNAS-related disorders.
• To differentiate between PHP type Ia (PHP1A), pseudopseudohypoparathyroidism (PPHP), and PHP type Ib (PHP1B).
• To understand the role of GNAS methylation patterns in disease pathogenesis.

Main Methods:

• Analysis of GNAS gene mutations (inactivating, deletions, duplications, insertions, inversions).
• Epigenetic analysis of GNAS differentially methylated regions (DMRs).
• Assessment of Gsα expression and function.
• Clinical evaluation of patients with AHO, hypocalcemia, and hyperphosphatemia.

Main Results:

• PHP1A results from heterozygous inactivating mutations in maternal GNAS exons, causing hormonal resistance and AHO.
• PPHP involves paternal GNAS mutations affecting Gsα, causing AHO features without hormonal resistance.
• PHP1B is linked to maternal GNAS/STX16 mutations and epigenetic changes, particularly loss of methylation at GNAS exon A/B, impairing Gsα expression.
• Sporadic PHP1B often shows epigenetic GNAS changes, including gain of methylation at the NESP DMR, though the genetic cause remains unknown in many cases.

Conclusions:

• Genetic and epigenetic abnormalities of the GNAS locus are key drivers of PHP and related disorders.
• Differential methylation at GNAS DMRs plays a critical role in regulating Gsα expression and function.
• Understanding these mechanisms is crucial for diagnosing and potentially treating GNAS-related conditions.